股下旁路术使用替代管道后无截肢生存与伤口愈合的预测因素
单中心回顾性研究纳入2013至2020年139例因慢性威胁肢体缺血(CLTI)行股下旁路术的病例,比较冷冻保存大隐静脉单段(cryovein)、聚四氟乙烯(PTFE)及臂/拼接静脉移植物的结局。cryovein组2年无截肢生存(AFS)为53%,低于臂/拼接静脉组的78%和PTFE组的79%,调整后风险比为2.5。cryovein组2年次级通畅率较差,但在组织缺损患者中伤口愈合率与其他类型旁路术无统计学显著差异。
要点
- cryovein组2年AFS为53%,低于臂/拼接静脉组的78%和PTFE组的79%,调整后HR为2.5。
- cryovein组2年次级通畅率为26%,低于臂/拼接静脉组的68%和PTFE组的89%。
- cryovein组中WIfI分期3或4、年龄>70岁及既往旁路失败者2年AFS最低为36%。
核心结论
- 在缺乏合适大隐静脉单段的CLTI患者中,使用自体臂/拼接静脉或PTFE行旁路术的无截肢生存优于cryovein,但PTFE用于远端靶血管的数据有限。
- 尽管cryovein通畅率差,多数病例仍可实现伤口愈合,但鉴于AFS率低,在年龄较大、WIfI分期高及既往旁路失败的患者中应谨慎使用。
研究设计与样本
- 单中心回顾性研究,纳入2013至2020年因CLTI行股下旁路术的139例病例,使用冷冻保存大隐静脉单段(cryovein)71例、PTFE 23例、臂/拼接静脉移植物45例。
- 记录患者特征、WIfI分期及结局,采用多变量Cox比例风险模型和分类回归树分析建模AFS的预测因素。
主要发现
- 139例中平均年龄71岁,男性占59%,非择期手术占51%。
- cryovein组WIfI分期4的比例为41%,高于PTFE组的13%和臂/拼接静脉组的27%(P = .04)。
- 2年AFS:臂/拼接静脉组78%,PTFE组79%,cryovein组53%;cryovein调整后风险比为2.5(P = .02)。
- cryovein组中WIfI分期3或4、年龄>70岁及既往旁路失败者2年AFS最低为36%,而具备少于两项上述因素的亚组AFS为58%至76%。
- 2年次级通畅率:cryovein组26%,臂/拼接静脉组68%,PTFE组89%(P < .01);组织缺损患者中cryovein组伤口愈合率72%,其他旁路类型为87%,无统计学显著差异(P = .12)。
临床怎么用
- 作者认为,在缺乏合适大隐静脉单段的CLTI患者中,使用自体臂/拼接静脉或PTFE行旁路术的无截肢生存优于cryovein。
- 作者认为,cryovein在年龄较大、WIfI分期高及既往旁路失败的患者中应谨慎使用。
局限性
- 原文指出PTFE管道用于远端靶血管的数据有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Inadequate vein quality or prior harvest precludes use of autologous single segment greater saphenous vein (ssGSV) in many patients with chronic limb-threatening ischemia (CLTI). Predictors of patient outcome after infrainguinal bypass with alternative (non-ssGSV) conduits are not well-understood. We explored whether limb presentation, bypass target, and conduit type were associated with amputation-free survival (AFS) after infrainguinal bypass using alternative conduits. METHODS: A single-center retrospective study (2013-2020) was conducted of 139 infrainguinal bypasses performed for CLTI with cryopreserved ssGSV (cryovein) (n = 71), polytetrafluoroethylene (PTFE) (n = 23), or arm/spliced vein grafts (n = 45). Characteristics, Wound, Ischemia, and foot Infection (WIfI) stage, and outcomes were recorded. Multivariable Cox proportional hazards and classification and regression tree analysis modeled predictors of AFS. RESULTS: Within 139 cases, the mean age was 71 years, 59% of patients were male, and 51% of cases were nonelective. More patients undergoing bypass with cryovein were WIfI stage 4 (41%) compared with PTFE (13%) or arm/spliced vein (27%) (P = .04). Across groups, AFS at 2 years was 78% for spliced/arm, 79% for PTFE, and 53% for cryovein (adjusted hazard ratio for cryovein, 2.5; P = .02). Among cases using cryovein, classification and regression tree analysis showed that WIfI stage 3 or 4, age >70 years, and prior failed bypass were predictive of the lowest AFS at 2 years of 36% vs AFS of 58% to 76% among subgroups with less than two of these factors. Although secondary patency at 2 years was worse in the cryovein group (26% vs 68% and 89% in arm/spliced and PTFE groups; P < .01), in patients with tissue loss there was no statistically significant difference in wound healing in the cryovein group (72%) compared with other bypass types (72% vs 87%, respectively; P = .12). CONCLUSIONS: In patients with CLTI lacking suitable ssGSV, bypass with autogenous arm/spliced vein or PTFE has superior AFS compared with cryovein, although data were limited for PTFE conduits for distal targets. Despite poor patency with cryovein, wound healing is achieved in a majority of cases, although it should be used with caution in older patients with high WIfI stage and prior failed bypass, given the low rates of AFS.
引用
- Matthay ZA, Pace WA, Smith EJ, et al. Predictors of amputation-free survival and wound healing after infrainguinal bypass with alternative conduits. J Vasc Surg. 2024. PMID: 38310981. doi:10.1016/j.jvs.2024.01.209
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。